Analysts Maintain Buy Ratings on Fresenius SE & Co. KGaA Amid Positive Insider Sentiment
核心洞察
J.P. Morgan (搜索) analyst David Adlington maintained a Buy rating on Fresenius SE & Co. KGaA (搜索) with a €56.60 price target.
UBS (搜索) analyst Graham Doyle also reiterated a Buy rating, setting a €56.00 price target on the healthcare company.
The Street consensus reflects a Strong Buy rating with a €55.28 average price target, supported by positive corporate insider sentiment.
Fresenius SE & Co. KGaA (搜索), a global healthcare group, received reaffirmed Buy ratings from two major financial institutions, underscoring continued analyst confidence in the company's outlook. J.P. Morgan (搜索) analyst David Adlington maintained a Buy rating with a price target of €56.60, while UBS (搜索) analyst Graham Doyle reiterated a Buy rating with a €56.00 price target.
The broader analyst community reflects a Strong Buy consensus rating for Fresenius SE & Co. KGaA (搜索), with an average price target of €55.28. The company currently holds a market capitalization of €24.82 billion and a price-to-earnings (P/E) ratio of 16.74.
Analyst Ratings and Price Targets
David Adlington of J.P. Morgan (搜索) maintained a Buy rating on Fresenius SE & Co. KGaA (搜索), setting a price target of €56.60. According to TipRanks, Adlington is ranked #12033 out of 12376 analysts.
In a separate report, Graham Doyle of UBS (搜索) also maintained a Buy rating on the stock, with a price target of €56.00. Doyle is ranked #10200 out of 12411 analysts, according to TipRanks.
Jefferies (搜索) likewise maintained a Buy rating on the stock with a €55.00 price target.
Market Performance and Valuation
Fresenius SE & Co. KGaA (搜索) has a one-year high of €52.96 and a one-year low of €35.11. The company currently has an average trading volume of 1.19 million shares. Its market capitalization stands at €24.82 billion, with a P/E ratio of 16.74.
Insider Activity and Sentiment
Based on recent corporate insider activity involving eight insiders, corporate insider sentiment is positive on the stock. Over the past quarter, there has been an increase in insiders buying shares of the company relative to earlier in the year, a signal that those closest to the business view its shares favorably.